{
  "variant": {
    "gene": "LRRK2",
    "protein_change": {
      "reference": "G",
      "alternate": "S",
      "position": 2019
    },
    "variant_string_id": "LRRK2 G2019S"
  },
  "functional_evidence_assessment": {
    "step_1": {
      "disease_mechanism_defined": true,
      "description": "The paper explicitly states that LRRK2 mutations, such as G2019S, are associated with Parkinson's disease (PD) and that pathogenic mutants exhibit increased kinase activity. This defines a clear disease mechanism (gain-of-function via elevated kinase activity)."
    },
    "step_2": {
      "assay_class_applicability": true,
      "description": "The general class of assay (enzyme activity assay, specifically kinase activity measurement) directly models the disease pathogenesis (gain-of-function due to increased kinase activity)."
    },
    "step_3": {
      "sub_step_3a": {
        "basic_controls_replicates": false,
        "description": "The paper does not explicitly mention the use of both 'Normal/Wild type' and 'Abnormal/Positive/Null' controls, nor does it state that experiments were performed with multiple replicates."
      },
      "sub_step_3b": {
        "assay_validity": true,
        "description": "The kinase activity assay is a broadly accepted and historically validated method in the field of protein function studies. No specific details on controls/replicates are provided, but the assay's general validity is assumed due to its standard use."
      },
      "sub_step_3c": {
        "variant_controls_used": false,
        "description": "The paper does not mention the use of known pathogenic or benign variants as controls in the assay for G2019S."
      }
    },
    "step_4": {
      "sub_step_4a": {
        "statistical_analyses_sufficient": false,
        "description": "The paper does not provide explicit statistical analyses (e.g., p-values, OddsPath calculations) to quantify the pathogenicity of G2019S."
      },
      "sub_step_4b": {
        "total_control_variants": 0,
        "description": "The paper does not report the number of benign/pathogenic control variants used in the study."
      },
      "sub_step_4c": {
        "odds_path_correlation": false,
        "description": "No OddsPath value or robust statistical metrics are provided for G2019S."
      }
    },
    "functional_evidence_strength": {
      "category": "PS3",
      "strength": "PS3_supporting",
      "rationale": "The kinase activity assay is a broadly accepted method (Sub-step 3b). While controls/replicates are not explicitly documented, the general class of assay is valid and models the disease mechanism defined in Step 1. The absence of OddsPath or detailed statistical analyses limits the strength to 'supporting' rather than 'moderate' or 'very strong'."
    }
  }
}